Significant Wealth Partners’s Viking Therapeutics VKTX Stock Holding History

Significant Wealth Partners’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$284K	Buy	7,284 +197	+3%	+$6.36K	0.31%	77
2026 Q1	$231K	Buy	7,087 +101	+1%	+$3.25K	0.28%	85
2025 Q4	$246K	Sell	6,986 -8,146	-54%	-$289K	0.27%	51
2025 Q3	$398K	Buy	15,132 +2,066	+16%	+$61.6K	0.19%	59
2025 Q2	$346K	Buy	13,066 +4,073	+45%	+$107K	0.17%	58
2025 Q1	$217K	Buy	8,993 +3,596	+67%	+$114K	0.11%	76
2024 Q4	$217K	Buy	+5,397	New	+$308K	0.11%	70

Other funds holding VKTX

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

FAM

Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

RFM

Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return

PAM

PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Significant Wealth Partners's VKTX Position: Q2 2026 in Review

Significant Wealth Partners increased its Viking Therapeutics (VKTX) stake by 2.8% in Q2 2026, buying an estimated $6.36K and bringing the position to 7,284 shares worth $284K. The position accounts for 0.31% of the portfolio, ranked #77.

Significant Wealth Partners first reported a position in VKTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $398K in Q3 2025. 44 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

Significant Wealth Partners held 7,284 shares of Viking Therapeutics worth $284K as of Q2 2026.
Significant Wealth Partners bought 197 Viking Therapeutics shares in Q2 2026, an estimated $6.36K.
Viking Therapeutics made up 0.31% of Significant Wealth Partners's portfolio in Q2 2026, its #77 holding.
Significant Wealth Partners first reported a position in Viking Therapeutics in Q4 2024 and has held it in 7 quarters since.
Significant Wealth Partners's Viking Therapeutics position peaked at $398K in Q3 2025.
44 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Significant Wealth Partners's 13F filing for Q2 2026, filed 14 Jul 2026.